slides · global inventory
Diagram
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 23,622
Current window 11,521-11,550
Pages 788
Rows per page 30
Component
11,521-11,550 of 23,622
50
The slide uses a circular flow diagram connecting 'Predict' and 'Learn' phases via an AI engine, culminating in drug creation.Absci | IPO Presentation Deck | 65 slides · Absci
Pitch deck Investment bank 1 hit
53
The diagram uses a series of nested 'L' shapes to show that the platform can be engaged at any point in the drug development lifecycle, with cumulative value represented by the arrows on the right.Absci | IPO Presentation Deck | 65 slides · Absci
Pitch deck Investment bank 1 hit
56
The diagram illustrates a network or hierarchy of molecule types, though it functions primarily as a visual list of capabilities.Absci | IPO Presentation Deck | 65 slides · Absci
Pitch deck Investment bank 1 hit
57
The slide uses a stylized, continuous line graphic to represent the progression of the partnership.Absci | IPO Presentation Deck | 65 slides · Absci
Pitch deck Investment bank 1 hit
58
The slide uses a hub-and-spoke diagram to illustrate the versatility of the company's protein platform.Absci | IPO Presentation Deck | 65 slides · Absci
Pitch deck Investment bank 1 hit
64
The slide uses a funnel-like process flow to show the reduction of variants from billions to tens.Absci | IPO Presentation Deck | 65 slides · Absci
Pitch deck Investment bank 1 hit
65
The slide uses a process flow diagram to show the transition from input sequences to functional embedding, homology search, and experimental validation.Absci | IPO Presentation Deck | 65 slides · Absci
Pitch deck Investment bank 1 hit
11
The slide combines a historical timeline with a financial growth chart.Allego | SPAC Presentation Deck | 37 slides · Allego
Pitch deck Investment bank Beat · SolutionLoop · Quick Win Big Bet1 hit
19
Uses a classic TAM/SAM/SOM style visualization with an additional outer layer for total fleet size.Allego | SPAC Presentation Deck | 37 slides · Allego
Pitch deck Investment bank 1 hit
21
The slide uses a circular Venn-like diagram to show how two business units complement each other under the Allego brand.Allego | SPAC Presentation Deck | 37 slides · Allego
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
24
The slide uses a hub-and-spoke layout to demonstrate market reach.Allego | SPAC Presentation Deck | 37 slides · Allego
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
26
The slide uses a timeline diagram to illustrate historical project wins and their scope.Allego | SPAC Presentation Deck | 37 slides · Allego
Pitch deck Investment bank Loop · Cost Of Inaction1 hit
09
The slide uses a hub-and-spoke visual metaphor to show the drug's broad applicability across multiple disease states.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations 1 hit
10
The slide uses a process-like flow to connect disease states to specific clinical data and future opportunities.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations 1 hit
12
The diagram is a variation of a flywheel or infinity loop process.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations 1 hit
14
The slide uses a Venn-like diagram to connect core company values to specific market and pipeline achievements.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations 1 hit
15
The slide uses a Venn-like diagram to connect three core pillars to six specific business achievements.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations 1 hit
20
The slide uses a causal flow diagram to explain the mechanism of action.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations 1 hit
25
The diagram uses a bubble-cluster visualization to show the relationship between different autoantibodies and clinical conditions.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
26
The slide uses a circular process flow to explain the pathology of Immune-Mediated Necrotizing Myopathy (IMNM).argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
27
The slide uses a process-flow framework to show how autoantibodies trigger specific biological pathways (myolysis, capillary disruption, interferon production) leading to muscle atrophy.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
28
The diagram illustrates a hub-and-spoke model where the autoantibody is the central mediator.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
36
The slide outlines a clinical trial protocol involving 180 patients, stratified by condition and severity, with a 26-week duration and specific primary/secondary endpoints.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
42
The funnel structure implies a progression toward higher selectivity and better outcomes.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Evidence & ProofLoop · Aha Moment1 hit
44
Uses a horizontal progression arrow to show the transition from initial indication to adjacent indications.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations 1 hit
45
Clinical trial design diagram showing a 1:1 randomization between Efgartigimod and Placebo over 36 weeks.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations 1 hit
50
The diagram shows the classical, lectin, and alternative pathways converging at C3 convertase, with C2 highlighted as a target.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
51
The slide uses a process flow diagram to illustrate the complement system and justifies targeting C2 over other components.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
52
The slide uses a process flow diagram to explain the mechanism of action for a potential therapeutic intervention.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit
53
The slide uses a biological pathway diagram to justify a therapeutic target.argenx SE | Investor Day Presentation Deck | 69 slides · argenx
Conference presentation Investor relations Beat · Impact & Next Steps1 hit